Search

everythinglearnresearchcommunity

for

Search:↓

People with hidradenitis suppurativa have a higher risk of kidney stones.

Stressful life events may trigger alopecia areata.

Trichoscopy effectively shows early positive effects of minoxidil in male pattern hair loss, improving patient satisfaction.

Bariatric surgery improved quality of life and health in six months, but hair loss was common.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Higher air pollution increases the risk of alopecia areata.

Fibrosing alopecia can be stabilized or improved with anti-inflammatory treatments and hair growth agents.

Ultraviolet techniques help identify Grover’s Disease, which may be underdiagnosed in young people and females.

Vaccination helps reduce long COVID symptoms in women with PCOS.

Low-dose oral minoxidil is safe for the heart in the short term for hair loss patients.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Alopecia areata patients have higher risks of infections, lymphoma, heart issues, and death.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

Two L-PRP treatments improve hair density in mild to moderate alopecia.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

Minoxidil with betamethasone is the most effective for hair regrowth in alopecia areata.

Baricitinib is effective for severe alopecia areata but has some side effects.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Omega-3 fatty acids may not help and could harm hair loss improvement in middle-aged or elderly men.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Neck burn scar contracture recurrence is more likely with larger neck defects, and closer follow-up can help detect it sooner.

Surgery for burn scar alopecia often involves multiple procedures, and treatment options should be more accessible to improve self-image.

Transgender and gender diverse youth often have skin issues like acne and scarring, but few get referred to dermatologists.

Having an appendectomy may increase the risk of developing alopecia areata.